Hirudoid

LEAFLET INCLUDED IN THE PACKAGE: INFORMATION FOR THE USER

Warning! Keep the leaflet, information on the immediate packaging in a foreign language!

HIRUDOID

0.3 g/100 g, gel

Mucopolysaccharide polysulfate

Read the leaflet carefully before using the medicine, as it contains important information for the patient.

• This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
• Keep this leaflet, so you can read it again if you need to.
• If you need advice or additional information, consult a pharmacist.
• If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet:

• 1. What is HIRUDOID and what is it used for
• 2. Important information before using HIRUDOID
• 3. How to use HIRUDOID
• 4. Possible side effects
• 5. How to store HIRUDOID
• 6. Package contents and other information

1. What is HIRUDOID and what is it used for

Mucopolysaccharide polysulfate belongs to a group of medicines used locally in cases of:

• blunt injuries with or without hematomas,
• superficial vein inflammation that cannot be treated with a compression bandage.

Hirudoid can also be used for phonophoresis and iontophoresis. During iontophoresis, the gel is applied under the cathode.

2. Important information before using HIRUDOID

When not to use HIRUDOID

If the patient is allergic to mucopolysaccharide polysulfate or any of the other ingredients of this medicine (listed in section 6).
Hirudoid contains isopropyl alcohol and should be avoided on open wounds, mucous membranes, and eyes.

Warnings and precautions

Before starting to use HIRUDOID, discuss it with your doctor or pharmacist.

Hirudoid and other medicines

Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
No interactions with other medicines have been found.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
The medicine can be used during pregnancy and breastfeeding.

Driving and using machines

Hirudoid does not affect the ability to drive vehicles or operate machinery.

Hirudoid contains 5 mg of propylene glycol per 1 g of gel

Propylene glycol may cause skin irritation.

3. How to use HIRUDOID

This medicine should always be used as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Hirudoid is for external use only, on the skin.
Recommended dose:
Hirudoid should be applied 2 to 3 times a day to the affected areas or, if necessary, more frequently. Depending on the size of the treated surface, usually 3 to 5 cm of gel is sufficient.
The Hirudoid gel should be gently massaged into the affected areas. Do not use the medicinal product under a dressing.
Treatment usually lasts up to 10 days for blunt injuries and 1 to 2 weeks for superficial vein inflammation. Hirudoid can also be used for phonophoresis and iontophoresis.
During iontophoresis, the gel is applied under the cathode.

Using more than the recommended dose of HIRUDOID

Due to the way HIRUDOID is administered, overdose is unlikely.
If symptoms of overdose occur, consult a doctor.
In the event of accidental ingestion of HIRUDOID, no symptoms of overdose caused by the active substance should occur.
Due to the presence of isopropyl alcohol, accidental ingestion of a large amount of HIRUDOID may cause alcohol poisoning, especially in children.
In the event of alcohol poisoning, appropriate symptomatic treatment should be applied immediately.

Missing a dose of HIRUDOID

Do not use a double dose to make up for a missed dose.
If you have any further doubts about using this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, HIRUDOID can cause side effects, although not everybody gets them.
Frequency less than 1 in 10,000 patients - very rare.
Very rare local hypersensitivity reactions, such as skin redness, may occur, which usually resolve quickly after discontinuation of the medicinal product.
Hirudoid contains propylene glycol, which may cause skin irritation.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store HIRUDOID

Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

Translation of some abbreviations on the immediate packaging:

Verw. bis -
Expiry date
Ch.-B. -
Batch number

6. Package contents and other information

What HIRUDOID contains

The active substance of HIRUDOID is mucopolysaccharide polysulfate 0.3 g/100 g. The other ingredients are:
sodium hydroxide, propylene glycol, carbomers, isopropyl alcohol, purified water.

What HIRUDOID looks like and what the pack contains

Aluminum tube with a screw cap in a cardboard box. Package size 40 g.
For more detailed information, contact the marketing authorization holder or parallel importer.

Marketing authorization holder in Austria, the country of export:

Stada Arzneimittel GmbH
Muthgasse 36/2
1190 Vienna
Austria

Manufacturer:

Mobilat Produktions GmbH
85276 Pfaffenhofen
Germany
Stada Arzneimittel AG
61118 Bad Vilbel
Germany

Parallel importer:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź

Repackaged by:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Austrian marketing authorization number: 14.830
Parallel import authorization number: 392/19

Date of leaflet approval: 09.10.2024

[Information about the trademark]